Kyle T Greenway

13PUBLICATIONS
35CO-AUTHORS
Physical organic chemistryMedical biotechnology diagnostics (incl. biosensors)Psychological methodology, design and analysisCardiology (incl. cardiovascular diseases)Traditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 17, 2026
Defining 'psychedelic'.

|Mar 21, 2026
Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.

Claudio Agnorelli, Joseph Peill, Gabriela Sawicka

|Jun 18, 2025
The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression.

Kyle T Greenway, Nicolas Garel, Lê-Anh L Dinh-Williams

|Jun 12, 2025
Cross-disciplinary cardiovascular and psychiatric recommendations: A systematic review of clinical guidelines.

Marina Delli Colli, Kyle T Greenway, Michael Goldfarb

|Jun 03, 2025
An international Delphi consensus for reporting of setting in psychedelic clinical trials.

Chloé Pronovost-Morgan, Kyle T Greenway, Leor Roseman

|Jan 27, 2025
The ketamine chameleon: history, pharmacology, and the contested value of experience.

Danny Diep, Sara de la Salle, Julien Thibault Lévesque

Pageof 3

Frequent Collaborators

4 joint publications

David Erritzoe

3 joint publications

Robin Carhart-Harris

2 joint publications

David Nutt

2 joint publications

Leor Roseman